UiPath Promotes Ramani to CFO, Adds Board Member, and Reports Q2 Revenue of $410M with FY27 Guidance
PATH has more than doubled off its 52-week low of $9.2.
Summary
UiPath reported Q2 FY27 revenue of $410 million (up 13% YoY) with GAAP operating income of $32 million, promoted Hitesh Ramani to CFO, added Yazdi Bagli to its board, and disclosed CEO Daniel Dines' 10b5-1 plan to sell up to 5 million shares.
Key Events · Earnings and Guidance · PATH
-
Q2 FY27 Revenue Beats at $410M
Revenue grew 13% year-over-year to $410 million, with ARR up 12% to $1.938 billion and GAAP operating income of $32 million.
-
CFO Transition to Hitesh Ramani
Hitesh Ramani promoted from Deputy CFO to CFO effective September 3, 2026, with $470,000 base salary, 50% target bonus, and 130,368 RSUs; Ashim Gupta remains COO.
-
Board Expansion with Yazdi Bagli
Board increased from 7 to 8 members with appointment of Yazdi Bagli, EVP of IT at Kaiser Permanente, as an independent director.
-
CEO 10b5-1 Plan for 5M Shares
Daniel Dines adopted a 10b5-1 plan on July 15, 2026 to sell up to 5,000,000 Class A shares through February 1, 2027, representing less than 5% of his holdings.
Analysis · PATH · Technology
A strong Q2 saw revenue climb 13% to $410 million and GAAP operating income reach $32 million, even as the executive suite underwent a reshuffle. Hitesh Ramani moves up from Deputy CFO to CFO, Ashim Gupta narrows his focus to COO, and Brad Brubaker expands his role to Chief Legal & Administrative Officer. The board also welcomed Yazdi Bagli from Kaiser Permanente. Against that backdrop, CEO Daniel Dines adopted a 10b5-1 plan to sell up to 5 million shares through February 2027 — a notable overhang even though it represents less than 5% of his holdings. The leadership changes and board expansion signal a deliberate push to sharpen execution as the company scales its AI orchestration platform.
How filings like this one have moved
In the 30 days to Sep 10, 2026, 30% of the 1963 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.14%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, PATH was trading at $18.99 on NYSE in the Technology sector, with a market capitalization of approximately $9.4B. The 52-week trading range was $9.20 to $19.84. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.